Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaike Chemical Group Regulatory News (HAIK)

  • There is currently no data for HAIK

Trading Statement

31 Jul 2012 08:36

RNS Number : 8926I
HaiKe Chemical Group Ltd.
31 July 2012
 



HaiKe Chemical Group Ltd

Trading Update

 

HaiKe Chemical Group Limited ("HaiKe" or the "Company"), the AIM quoted (AIM: HAIK) petrochemical, specialty chemical and biochemical business based in China, today provides an update on trading ahead of its interim results for the six months period ended 30 June 2012.

 

The following represent the key points in the Company's trading performance:

 

·; The Company recorded slight turnover growth year-on-year in 1H, mainly driven by a price increase in the refinery division. Nevertheless, diesel sales volume fell by 15% year-on-year as a consequence of the weakening economy. The refinery division made a gross profit but a net loss in 1H 2012.

 

·; Both specialty and salt chemicals recorded volume increases in 1H, however prices have fallen as a result of a sluggish domestic economy. Both Dongying Hi-Tech Spring Chemical Co., Ltd. ("Hi-Tech Spring") and Shandong Hi-Tech Shengli Electrochemical ("Hi-Tech Shengli") remained profitable. Biochemicals recorded a strong increase in sales and generated its largest profit yet.

 

·; Dongying Hebang Chemical Co., Ltd. ("Hebang"), which produces specialty and salt chemical products, commenced commercial operation in late March of this year. The sale of its first product, Trichloroethylene ("TCE"), was disappointing in 2Q due a reduction in market demand. Hebang is currently breaking even at the gross margin level. New products, including caustic soda, come on stream later this year and are expected to improve Hebang's performance.

 

·; The gross margin at group level fell from 4.6% in 1H 2011 to 1.1% in 1H 2012. Selling, general and administration expenses increased due to more aggressive marketing efforts and a one-off internal departmental restructuring. As a result, the margins are negative at the operating level compared with a positive 2.8% margin in 1H 2011. 

 

·; The Company acquired the minority interest in Shandong Hi-Tech Ruilin Chemical Co., Ltd. ("Hi-Tech Ruilin") in 1H 2012. Management expects the buyout to benefit the Company's overall profitability in the medium to long run by improving internal synergies.

 

·; The Company continues to improve internal efficiency and technological innovation. During the period, several key departments were centralised and managerial staff of several key subsidiaries were rotated in order to enhance control and improve internal efficiency. There were breakthroughs on technology innovation in 1H: Hi-Tech Ruilin's "Dry Gas Recovery" technique, which substitutes the fuel coal outsourced with self-generated dry gas, was rewarded a one-off government subsidy of RMB7.6 million by the National Development and Reform Commission. This new technique is expected to generate cost savings of RMB20 million per annum for the Company.

 

Mr. Xiaohong Yang, Executive Chairman said:

 

"The weakening domestic economy and lower demand presents us with a challenging operating environment and to this end, our main priorities will be to generate further cost savings and stabilise our earnings by streamlining our operations and improving internal synergies. We have made good progress in our strategic move to speciality chemicals and will continue to focus on growing this higher margin business which will be key to improving our overall profitability."

 

 

Further enquiries

 

HaiKe Chemical Group

George Zeng, Chief Financial Officer

george@haikechemical.com

+86 138 2520 2570

Westhouse Securities

Tom Price / Martin Davison

+44 (0) 20 7601 6100

Cardew Group

Shan Shan Willenbrock

Alexandra Stoneham

haike@cardewgroup.com

+44 (0) 20 7930 0777

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFMGFNNMMGZZG
Date   Source Headline
20th Apr 20099:13 amRNSRe Joint Venture
1st Apr 20097:00 amRNSChange of Adviser
16th Mar 20097:00 amRNSAppointment of Chief Financial Officer
12th Nov 20081:39 pmRNSTrading Statement Replacement
11th Nov 20088:44 amRNSTrading Statement
26th Sep 20087:00 amRNSProduction Update
17th Sep 20087:00 amRNSInterim Results
8th Sep 20088:45 amRNSMajor Contract & Project Comm
8th Sep 20087:00 amRNSNotice of Results
4th Sep 20087:00 amRNSCompany Update
23rd Jul 20082:01 pmRNSTrading Statement
11th Jul 200812:57 pmRNSDirector/PDMR Shareholding
11th Jul 200812:54 pmRNSDirector/PDMR Shareholding
10th Jul 20087:00 amRNSSpeciality chemical facility
20th Jun 200811:23 amRNSTrading Statement
20th Jun 20087:14 amRNSResult of AGM
20th Jun 20087:00 amRNS1st Quarter Results
11th Jun 20082:41 pmRNSNotice of Results
23rd May 200812:34 pmRNSAnnual Report and Accounts
30th Apr 20087:01 amRNSHolding(s) in Company
7th Apr 20087:01 amRNSFinal Results
1st Apr 20087:00 amRNSNotice of Results
31st Mar 20089:27 amRNSStmnt re Share Price Movement
17th Dec 20074:38 pmRNSDirector/PDMR Shareholding
17th Dec 20079:38 amRNSDirector/PDMR Shareholding
12th Dec 200711:15 amRNSTrading Update
19th Nov 20077:00 amRNS3rd Quarter Results
2nd Nov 200710:24 amRNSTrading Statement
9th Oct 20071:00 pmRNSDirector/PDMR Shareholding
27th Sep 20072:24 pmRNSDirector/PDMR Shareholding
21st Sep 20079:43 amRNSTrading Statement
18th Sep 20079:00 amRNSTransfer of minority stake
10th Sep 20077:01 amRNSInterim Results
24th Aug 20071:53 pmRNSHolding(s) in Company
17th Aug 200711:24 amRNSAIM Rule 26
15th Aug 20071:33 pmRNSNotice of Results
20th Jun 200710:11 amRNSAGM Statement
1st Jun 200712:34 pmRNSDirector/PDMR Shareholding
30th May 20075:04 pmRNSDirector/PDMR Shareholding
24th May 20077:00 amRNS1st Quarter Results
22nd May 20077:01 amRNSShareholder Documentation
17th May 20078:43 amRNSNotice of Results
3rd Apr 20079:13 amRNSDirector/PDMR Shareholding
3rd Apr 20077:01 amRNSFinal Results
27th Mar 20073:12 pmRNSNotice of Results
15th Feb 20075:03 pmRNSHolding(s) in Company
14th Feb 20078:00 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.